Overview
Advances in understanding how tumors evade and suppress the immune system have led to new approaches in cancer immunotherapy, bringing the potential to treat, and even cure, advanced disease. Surface is developing new classes of cancer immunotherapeutics with the goal of expanding the reach of these novel agents to every patient.